Core Insights - The 2025 13th New Nutrition Conference was held in Hangzhou, Zhejiang, gathering over 1,000 industry experts and representatives to discuss cutting-edge research, innovative technologies, and applications in the nutrition and health sector [1] - A joint white paper titled "2025 China Maternal and Infant Source Probiotics Research and Application" was released by Aoyou, Jinqi Bio, and the Yili Innovation Center, highlighting the importance of maternal and infant probiotics in health and immune development [3][4] - Jinqi Bio's product, Yizhi Xian® dietary fiber probiotic powder, won the "Best-Selling Product Award" in the meal replacement and weight management category at the conference [1][6] Industry Trends - Probiotics research has become a significant topic in global nutrition and health, with a focus on maternal and infant probiotics as key regulators of the human microbiome [3] - The white paper emphasizes the unique characteristics of the gut microbiota in Chinese populations and discusses the clinical applications of specific probiotic strains in alleviating functional digestive disorders and reducing body fat [3][4] - The industry is moving towards standardization and regulation, with the white paper providing forward-looking insights on industry standards and future trends [3] Company Developments - Jinqi Bio has developed a complete industrial chain for the production and commercialization of high-value probiotic strains, including YLGB-1496 and CP-9, which have received multiple Chinese invention patents [4][5][6] - The company has successfully integrated these probiotics into various Yili products, such as yogurt, milk powder, ice cream, and cheese, receiving positive consumer feedback [6] - Jinqi Bio aims to continue innovating and developing high-quality probiotics to meet the diverse health needs of consumers, adhering to the principle of "using infant-level standards to create better probiotics" [9]
《2025中国母婴源益生菌研究及应用白皮书》正式发布,推动科技创新与产业发展
Zhong Guo Shi Pin Wang·2025-06-06 09:51